Hypoxia Induces an Immunodominant Target of Tuberculosis Specific T Cells Absent from Common BCG Vaccines

M. tuberculosis (MTB) species-specific antigenic determinants of the human T cell response are important for immunodiagnosis and vaccination. As hypoxia is a stimulus in chronic tuberculosis infection, we analyzed transcriptional profiles of MTB subject to 168 hours of hypoxia to test the hypothesis...

Full description

Saved in:
Bibliographic Details
Published inPLoS pathogens Vol. 6; no. 12; p. e1001237
Main Authors Gideon, Hannah Priyadarshini, Wilkinson, Katalin Andrea, Rustad, Tige R., Oni, Tolu, Guio, Heinner, Kozak, Robert Andrew, Sherman, David R., Meintjes, Graeme, Behr, Marcel A., Vordermeier, Hans Martin, Young, Douglas Brownlee, Wilkinson, Robert John
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.12.2010
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:M. tuberculosis (MTB) species-specific antigenic determinants of the human T cell response are important for immunodiagnosis and vaccination. As hypoxia is a stimulus in chronic tuberculosis infection, we analyzed transcriptional profiles of MTB subject to 168 hours of hypoxia to test the hypothesis that upregulation by hypoxia might result in gene products being recognized as antigens. We identified upregulation of two region of difference (RD) 11 (Rv2658C and Rv2659c), and one RD2 (Rv1986) absent from commonly used BCG strains. In MTB infected persons, the IL-2 ELISpot response to Rv1986 peptides was several times greater than the corresponding IFN-γ response to the reference immunodominant ESAT-6 or CFP-10 antigens. The IL-2 response was confined to two epitopic regions containing residues 61-80 and 161-180. The biggest population of IL-2 secreting T cells was single cytokine positive central memory T cells. The IL-2 response to live MTB bacilli lacking Rv1986 was significantly lower than the response to wild type or mutant complemented with Rv1986. In addition, the IL-2 response to Rv1986 was significantly lower in HIV-TB co-infected persons than in HIV uninfected persons, and significantly increased during antiretroviral therapy. These findings demonstrate that Rv1986 is an immunodominant target of memory T cells and is therefore of relevance when considering the partial efficacy of currently used BCG vaccines and provide evidence for a clinical trial comparing BCG strains.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceived and designed the experiments: HPG KAW TRR DRS GM MAB HMV DBY RJW. Performed the experiments: HPG KAW TRR TO HG. Analyzed the data: HPG KAW TRR RJW. Contributed reagents/materials/analysis tools: KAW TRR TO HG RAK DRS GM MAB HMV DBY RJW. Wrote the paper: HPG TRR DBY RJW.
ISSN:1553-7374
1553-7366
1553-7374
DOI:10.1371/journal.ppat.1001237